Key result
Even mild ischemic stroke significantly compromised baroreflex sensitivity and cardiovagal modulation within the first week, but these autonomic dysfunctions almost completely recovered after 3 months.
Why the study?
Longitudinal post-stroke cardiovascular-autonomic modulation alterations remained unclear because previous studies excluded patients receiving cardiovascular medication.
Does standard cardiovascular medication promote recovery of cardiovascular-autonomic modulation in patients with acute ischemic stroke?
Observational (n=112)
No
Does standard cardiovascular medication promote recovery of cardiovascular-autonomic modulation in patients with acute ischemic stroke?
Cardiovascular autonomic dysfunction after mild ischemic stroke recovers almost completely by 3 months, likely promoted by cardiovascular medications, though slight dysfunction at 6 months suggests ongoing vulnerability.
Answers are grounded in this paper and cite their sources.
CAM monitoring feasible in medicated stroke patients; leaves open whether dysfunction improves over months.
BACKGROUND: Stroke may compromise cardiovascular-autonomic modulation (CAM). The longitudinal post-stroke CAM alterations remain unclear as previous studies excluded patients with cardiovascular medication. This study evaluated whether CAM dysfunction improves after several months in patients under typical clinical conditions, i.e., without excluding patients with cardiovascular medication. METHODS: In 82 ischemic stroke patients [33 women, 64.9 ± 8.9 years, NIHSS-scores 2 (interquartile range 1-5)], we evaluated the applications of cardiovascular medication before stroke, during autonomic tests performed within 1 week, 3 and 6 months after stroke onset. We determined resting RR intervals (RRI), systolic, diastolic blood pressures (BPsys), respiration, parameters reflecting total CAM [RRI-standard deviation (RRI-SD), RRI-total powers], sympathetic [RRI-low-frequency powers (RRI-LF), BPsys-LF powers] and parasympathetic CAM [RMSSD, RRI-high-frequency powers (RRI-HF powers)], and baroreflex sensitivity. ANOVA or Friedman tests with post hoc analyses compared patient data with data of 30 healthy controls, significance was assumed for P < 0.05. RESULTS: More patients had antihypertensive medication after than before stroke. First-week CAM testing showed lower RRIs, RMSSD, RRI-SDs, RRI-total powers, RRI-HF powers, and baroreflex sensitivity, but higher BPsys-LF powers in patients than controls. After 3 and 6 months, patients had significantly higher RRIs, RRI-SDs, RRI-total powers, RMSSDs, RRI-HF powers, and baroreflex sensitivity, but lower BPsys-LF powers than in the 1st week; RMSSDs and RRI-HF powers no longer differed between patients and controls. However, 6-month values of RRIs, RRI-SDs, and baroreflex sensitivity were again lower in patients than controls. CONCLUSIONS: Even mild strokes compromised cardiovagal modulation and baroreflex sensitivity. After 3 months, CAM had almost completely recovered. Recovery might be related to the mild stroke severity. Presumably, CAM recovery was also promoted by the increased application of cardiovascular medication. Yet, slight CAM dysfunction after 6 months suggests continuing autonomic vulnerability.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted an observational in Acute ischemic stroke (n=112). Ischemic stroke vs. Healthy controls was evaluated on Baroreflex sensitivity (BRS) within 1 week after stroke (ms/mmHg) (p=<0.001). Even mild ischemic stroke significantly compromised baroreflex sensitivity and cardiovagal modulation within the first week, but these autonomic dysfunctions almost completely recovered after 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: